[Gerontologic evaluation of the effect of bencyclane].
D000367:Age Factors; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003508:Cycloheptanes / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000188:drug therapy; D004569:Electroencephalography; D005260:Female; D005650:Fumarates / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009991:Oscillometry; D010276:Parasympatholytics / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D011437:Propylamines / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D014797:Vital Capacity
D003508:Cycloheptanes; D005650:Fumarates; D010276:Parasympatholytics; D011437:Propylamines
Gerontologische Bewertung der Wirkung von Bencyclan.